Insider Transactions
Showing insider trading activity for REED JOHN C.
Insider Trading Activity Chart
Visualizing insider transactions on stock price candles
Transaction Type
Insider Role
Min Transaction Value
No stock price data available.
Recent Filings
| Symbol | Name | Filed | Transaction | Type | Role | Shares |
|---|---|---|---|---|---|---|
| JNJ | REED JOHN C | 4 May 2026 | 1 May 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 25,255 |
| JNJ | REED JOHN C | 4 May 2026 | 1 May 2026 | F-InKind | EVP, Innovative Medicine, R&D | 11,002 |
| JNJ | REED JOHN C | 4 May 2026 | 1 May 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 25,255 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 1,847 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 1,847 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | F-InKind | EVP, Innovative Medicine, R&D | 385 |
| JNJ | REED JOHN C | 18 Feb 2026 | 17 Feb 2026 | S-Sale | EVP, Innovative Medicine, R&D | 2,283 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 1,349 |
| JNJ | REED JOHN C | 18 Feb 2026 | 17 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 21,721 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | F-InKind | EVP, Innovative Medicine, R&D | 528 |
| JNJ | REED JOHN C | 18 Feb 2026 | 17 Feb 2026 | S-Sale | EVP, Innovative Medicine, R&D | 29,927 |
| JNJ | REED JOHN C | 18 Feb 2026 | 17 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 29,927 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | A-Award | EVP, Innovative Medicine, R&D | 49,382 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | A-Award | EVP, Innovative Medicine, R&D | 3,546 |
| JNJ | REED JOHN C | 18 Feb 2026 | 17 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 21,721 |
| JNJ | REED JOHN C | 18 Feb 2026 | 17 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 29,927 |
| JNJ | REED JOHN C | 18 Feb 2026 | 15 Feb 2026 | M-Exempt | EVP, Innovative Medicine, R&D | 1,349 |
| JNJ | REED JOHN C | 20 Oct 2025 | 17 Oct 2025 | M-Exempt | EVP, Innovative Medicine, R&D | 21,721 |
| JNJ | REED JOHN C | 20 Oct 2025 | 17 Oct 2025 | S-Sale | EVP, Innovative Medicine, R&D | 21,721 |
| JNJ | REED JOHN C | 20 Oct 2025 | 17 Oct 2025 | M-Exempt | EVP, Innovative Medicine, R&D | 21,721 |